MEDIROM Healthcare Technologies Inc. Regains Compliance with Nasdaq Listing Standard
22 Aprile 2022 - 10:05PM
MEDIROM Healthcare Technologies Inc. (Nasdaq CM: MRM), a holistic
healthcare company based in Japan (the “Company”), announced today
that it has received notice from The Nasdaq Stock Market LLC
(“Nasdaq”) on April 19, 2022 informing the Company that it has
regained compliance with the minimum market value of listed
securities standard under Nasdaq Listing Rule 5550(b)(2) for
continued listing on The Nasdaq Capital Market.
On January 18, 2022, Nasdaq notified the Company
that it had failed to maintain a minimum market value of listed
securities of $35 million over the previous 30 consecutive business
days as required by The Nasdaq Capital Market set forth in Listing
Rule 5550(b)(2) (the “Rule”). Following its notification in January
2022, Nasdaq has determined that for 10 consecutive business days,
from April 10, 2022 to April 19, 2022, the Company’s market value
of listed securities has been $35,000,000 or greater. Accordingly,
the Company has regained compliance with the Rule and the matter is
now closed.
About MEDIROM Healthcare Technologies
Inc.MEDIROM, a holistic healthcare company, operates 310
(as of March 31, 2022) relaxation salons across Japan, Re.Ra.Ku®,
being its leading brand, and provides healthcare services. In 2015,
MEDIROM entered the health tech business, and launched new
healthcare programs using on-demand training app called “Lav®”,
which is developed by the company. MEDIROM also entered the device
business in 2020 and is developing a smart tracker “MOTHER
Bracelet™” (formerly known as “MOTHER Tracker®”). MEDIROM hopes
that its diverse health related services and products offering will
help it collect and manage healthcare data from users and customers
and enable it to become a leader in big data in the healthcare
industry. For more information, please
visit https://medirom.co.jp/en
Forward-Looking
StatementsCertain statements in this press release are
forward-looking statements for purposes of the safe harbor
provisions under the U.S. Private Securities Litigation Reform Act
of 1995. Forward-looking statements may include estimates or
expectations about the Company’s possible or assumed operational
results, financial condition, business strategies and plans, market
opportunities, competitive position, industry environment, and
potential growth opportunities. In some cases, forward-looking
statements can be identified by terms such as “may,” “will,”
“should,” “design,” “target,” “aim,” “hope,” “expect,” “could,”
“intend,” “plan,” “anticipate,” “estimate,” “believe,” “continue,”
“predict,” “project,” “potential,” “goal,” or other words that
convey the uncertainty of future events or outcomes. These
statements relate to future events or to the Company’s future
financial performance, and involve known and unknown risks,
uncertainties and other factors that may cause the Company’s actual
results, levels of activity, performance, or achievements to be
materially different from any future results, levels of activity,
performance or achievements expressed or implied by these
forward-looking statements. You should not place undue reliance on
forward-looking statements since they involve known and unknown
risks, uncertainties and other factors which are, in some cases,
beyond the Company’s control and which could, and likely will,
materially affect actual results, levels of activity, performance
or achievements. Any forward-looking statement reflects the
Company’s current views with respect to future events and is
subject to these and other risks, uncertainties and assumptions
relating to the Company’s operations, results of operations, growth
strategy and liquidity. The Company assumes no obligation to
publicly update or revise these forward-looking statements for any
reason, or to update the reasons actual results could differ
materially from those anticipated in these forward-looking
statements, even if new information becomes available in the
future.
Contacts
Investor Relations Team
ir@medirom.co.jp
Or
U.S. Investor Contact
Robert Blum, Joe Diaz, Joe Dorame
Lytham Partners, LLC
602-889-9700
MRM@lythampartners.com
Grafico Azioni MEDIROM Healthcare Techn... (NASDAQ:MRM)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni MEDIROM Healthcare Techn... (NASDAQ:MRM)
Storico
Da Lug 2023 a Lug 2024